Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK2 | O60674 | 7/20 | 0.56 |
| ▸ | JAK3 | P52333 | 4/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.56 |
| ▸ | CYP2C8 | P10632 | 3/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.56 |
| ▸ | JAK1 | P23458 | 3/20 | 0.56 |
| ▸ | TYK2 | P29597 | 3/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.56 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | NTRK1 | P04629 | 3/20 | 0.41 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.41 |
| ▸ | LIMK2 | P53671 | 1/20 | 0.41 |
| ▸ | AURKA | O14965 | 4/20 | 0.38 |
| ▸ | SYK | P43405 | 2/20 | 0.38 |
| ▸ | AURKB | Q96GD4 | 3/20 | 0.38 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.37 |
| ▸ | PLK4 | O00444 | 2/20 | 0.36 |
| ▸ | PAK4 | O96013 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12105320 | 0.89 | JAK2 (0.62) | JAK2JAK3CYP3A4CYP2C8CYP2C9 | |
| SCHEMBL12102480 | 0.89 | JAK2 (0.45) | JAK2JAK3CYP3A4CYP2C8CYP2C9 | |
| SCHEMBL13521363 | 0.87 | JAK2 (0.60) | JAK2JAK3CYP3A4CYP2C8CYP2C9 | |
| SCHEMBL1298293 | 0.86 | JAK2 (0.59) | JAK2JAK3CYP3A4CYP2C8CYP2C9 | |
| SCHEMBL12102489 | 0.86 | JAK2 (0.43) | JAK2JAK3CYP3A4CYP2C8CYP2C9 | |
| SCHEMBL12102462 | 0.85 | JAK2 (0.57) | JAK2JAK3CYP3A4CYP2C8CYP2C9 | |
| SCHEMBL12102470 | 0.83 | JAK2 (0.40) | JAK2JAK3CYP3A4CYP2C8CYP2C9 | |
| SCHEMBL12102306 | 0.82 | JAK2 (0.63) | JAK2JAK3CYP3A4CYP2C8CYP2C9 | |
| SCHEMBL12105335 | 0.82 | JAK2 (0.40) | JAK2JAK3CYP3A4CYP2C8CYP2C9 | |
| SCHEMBL12105318 | 0.76 | JAK2 (0.48) | JAK2JAK3CYP3A4CYP2C8CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110269740-A1 | JAK KINASE MODULATING COMPOUNDS AND METHODS OF USE THEREOF | AMBIT BIOSCIENCES CORPORATION | 2011-11-03 | — | — | US | disclosed |
| US-20110269740-A1 | JAK KINASE MODULATING COMPOUNDS AND METHODS OF USE THEREOF | AMBIT BIOSCIENCES CORPORATION | 2011-11-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110269740-A1 | JAK KINASE MODULATING COMPOUNDS AND METHODS OF USE THEREOF | JAK2, JAK1, JAK3 | JAK2 1/4885JAK3 3/4885CYP3A4 3372/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.